Electrophysiological properties and structural prediction of the SARS-CoV-2 viroprotein E

Front Mol Biosci. 2024 Mar 28:11:1334819. doi: 10.3389/fmolb.2024.1334819. eCollection 2024.

Abstract

COVID-19, the infectious disease caused by the most recently discovered coronavirus SARS- CoV-2, has caused millions of sick people and thousands of deaths all over the world. The viral positive-sense single-stranded RNA encodes 31 proteins among which the spike (S) is undoubtedly the best known. Recently, protein E has been reputed as a potential pharmacological target as well. It is essential for the assembly and release of the virions in the cell. Literature describes protein E as a voltage-dependent channel with preference towards monovalent cations whose intracellular expression, though, alters Ca2+ homeostasis and promotes the activation of the proinflammatory cascades. Due to the extremely high sequence identity of SARS-CoV-2 protein E (E-2) with the previously characterized E-1 (i.e., protein E from SARS-CoV) many data obtained for E-1 were simply adapted to the other. Recent solid state NMR structure revealed that the transmembrane domain (TMD) of E-2 self-assembles into a homo-pentamer, albeit the oligomeric status has not been validated with the full-length protein. Prompted by the lack of a common agreement on the proper structural and functional features of E-2, we investigated the specific mechanism/s of pore-gating and the detailed molecular structure of the most cryptic protein of SARS-CoV-2 by means of MD simulations of the E-2 structure and by expressing, refolding and analyzing the electrophysiological activity of the transmembrane moiety of the protein E-2, in its full length. Our results show a clear agreement between experimental and predictive studies and foresee a mechanism of activity based on Ca2+ affinity.

Keywords: calcium conduction; electrophysiology; envelope (E) protein; ionic conductance; molecular modelling and simulations; pore-forming peptide; protein arrangement; single channel recordings.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The research was supported by EU funding within the Next-Generation EU-MUR PNRR (Extended Partnership Initiative on Emerging Infectious Diseases Project no. PE00000007-INF-ACT), M4C2-Investimento 1.4 (Project no. CN0000004), PRIN-PNRR-2022 n. P2022247YC.